» Authors » Philippe Derost

Philippe Derost

Explore the profile of Philippe Derost including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 632
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, et al.
Parkinsonism Relat Disord . 2025 Mar; 134:107777. PMID: 40088781
Context: Previous studies assessing adapted physical activity (APA) in Parkinson's disease (PD) have been very heterogeneous regarding methodology and intervention, and have generally not addressed the question of combining various...
2.
Marques A, Pereira B, Simonetta-Moreau M, Castelnovo G, de Verdal M, Fluchere F, et al.
N Engl J Med . 2023 Nov; 389(19):1753-1765. PMID: 37937777
Background: Local injections of botulinum toxin type A have been used to treat essential head tremor but have not been extensively studied in randomized trials. Methods: In a multicenter, double-blind,...
3.
El Ouadih Y, Marques A, Pereira B, Luisoni M, Claise B, Coste J, et al.
Acta Neurochir (Wien) . 2023 Oct; 165(12):3927-3941. PMID: 37889334
Background: Subthalamic nucleus (STN) deep brain stimulation (DBS) alleviates severe motor fluctuations and dyskinesia in Parkinson's disease, but may result in speech and gait disorders. Among the suspected or demonstrated...
4.
Jalenques I, Guiguet-Auclair C, Cyrille D, Debosque C, Derost P, Hartmann A, et al.
PLoS One . 2022 Nov; 17(11):e0278383. PMID: 36449509
Introduction: The aim of this study was to create a new version of the French GTS-QOL adapted to adolescents with GTS aged 12-16 years (GTS-QOL-French-Ado) and to evaluate its psychometric...
5.
Besse-Pinot E, Pereira B, Durif F, Fantini M, Durand E, Debilly B, et al.
Neurology . 2021 Oct; 97(20):e1994-e2006. PMID: 34667082
Background And Objectives: To determine whether patients with Parkinson disease (PD) eligible for subthalamic nucleus deep brain stimulation (STN-DBS) with probable REM sleep behavior disorder (RBD) preoperatively could be more...
6.
Jalenques I, Cyrille D, Derost P, Hartmann A, Lauron S, Jameux C, et al.
PLoS One . 2020 Dec; 15(12):e0243912. PMID: 33351837
Introduction: The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL) is a self-rated disease-specific questionnaire to assess health-related quality of life of subjects with GTS. Our aim was to...
7.
Conde S, Marques A, Derost P, Debilly B, Lauxerois M, Chanson E, et al.
Parkinsonism Relat Disord . 2020 Aug; 78:68-69. PMID: 32739839
No abstract available.
8.
Marques A, Beze S, Pereira B, Chassain C, Monneyron N, Delaby L, et al.
J Neurol . 2020 May; 267(10):2829-2841. PMID: 32447550
Introduction: Whether different mechanisms, particularly ocular pathology, could lead to the emergence of visual hallucinations (VH) (defined as false perceptions with no external stimulus) versus visual illusions (VI) (defined as...
9.
De Chazeron I, Durif F, Chereau-Boudet I, Fantini M, Marques A, Derost P, et al.
Eat Weight Disord . 2019 Feb; 24(3):421-429. PMID: 30715681
Purpose: Eating disorders are common in Parkinson's disease (PD) patients and often class in Impulse control disorders, however, little is known about their phenomenology. Specific symptoms and comorbidities were described...
10.
Marques A, Figorilli M, Pereira B, Derost P, Debilly B, Beudin P, et al.
Sleep Med . 2018 Jun; 48:148-154. PMID: 29913341
Background: Although dopamine replacement therapy is the main risk factor for the occurrence of Impulse Control Disorders (ICDs) in Parkinson's disease (PD), non-pharmacological risk factors for have also been identified...